IRegained Inc.


Developer of a targeted, patient-driven hand rehabilitation system that integrates a multi–degree-of-freedom mechatronic device, companion software (assessment, pre-programmed and custom therapy protocols, gamification), and a cloud-connected analytics/dashboard platform. The company conducts multi-site clinical validation, publishes neurorehabilitation research, and provides clinician training, service, and remote monitoring capabilities.

Industries

assistive-technology
health-care
home-health-care
medical
medical-device

Nr. of Employees

small (1-50)


Patents

System and method for providing indirect movement feedback during sensorimotor function rehabilitation and enhancement

US-11596831-B2

View Details

Products

Targeted hand rehabilitation system (mechatronic device + app + dashboard)

Integrated rehabilitation solution comprising a passive, adjustable multi-finger mechatronic device, a companion application with built-in assessment and pre-programmed/custom protocols with gamified interfaces, and a cloud dashboard for analytics and clinician monitoring.


Services

On-site or virtual product demonstrations and clinical evaluation requests for rehabilitation providers.

Online library, tutorials, webinars, in-app help and clinical training materials for clinicians and users.

Warranty, repair turnaround, on-site maintenance options, hot-swap/loaner devices and a customer service ticketing process.

Expertise Areas

  • Hand neurorehabilitation
  • Digital neurotherapeutics (DTx)
  • Clinical trial execution and multi-site validation
  • Mechatronic device engineering for rehabilitation
  • Show More (3)

Key Technologies

  • Mechatronic multi-degree-of-freedom hand orthosis (passive device)
  • Cloud-connected IoMT platform
  • AI-driven clinical analytics
  • Gamified rehabilitation software
  • Show More (4)

News & Updates

Multiple peer-reviewed abstracts and conference presentations reporting functional, neurophysiological and EMG/TMS findings from clinical studies of the hand-function therapy device.

Patents granted in the USA and China; device listing/registration with the U.S. FDA and progress toward Canadian Medical Device Establishment License and commercialization.

Raised CAD 1.15 million in an oversubscribed round and received governmental and foundation funding to support clinical validation and commercialization.

Announced commercial distribution agreements and strategic partnerships for cloud services and APAC distribution; collaborations with multiple academic and clinical partners for research.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.